nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—Paclitaxel—breast cancer	0.13	0.58	CrCtD
Cabazitaxel—Microtubule Inhibition—Eribulin—breast cancer	0.0974	0.335	CiPCiCtD
Cabazitaxel—Microtubule Inhibition—Ixabepilone—breast cancer	0.0974	0.335	CiPCiCtD
Cabazitaxel—Docetaxel—breast cancer	0.0939	0.42	CrCtD
Cabazitaxel—Docetaxel—Paclitaxel—breast cancer	0.0752	0.58	CrCrCtD
Cabazitaxel—Microtubule Inhibition—Paclitaxel—breast cancer	0.0559	0.192	CiPCiCtD
Cabazitaxel—Paclitaxel—Docetaxel—breast cancer	0.0544	0.42	CrCrCtD
Cabazitaxel—TUBB3—breast cancer	0.0431	0.435	CbGaD
Cabazitaxel—Microtubule Inhibition—Docetaxel—breast cancer	0.0404	0.139	CiPCiCtD
Cabazitaxel—SLCO1B1—breast cancer	0.0305	0.308	CbGaD
Cabazitaxel—ABCG2—breast cancer	0.0133	0.134	CbGaD
Cabazitaxel—CYP3A4—breast cancer	0.00663	0.067	CbGaD
Cabazitaxel—TUBB2A—Eribulin—breast cancer	0.00596	0.0321	CbGbCtD
Cabazitaxel—TUBB2B—Eribulin—breast cancer	0.00596	0.0321	CbGbCtD
Cabazitaxel—TUBB4A—Eribulin—breast cancer	0.00596	0.0321	CbGbCtD
Cabazitaxel—TUBB8—Eribulin—breast cancer	0.00596	0.0321	CbGbCtD
Cabazitaxel—TUBB6—Eribulin—breast cancer	0.00596	0.0321	CbGbCtD
Cabazitaxel—TUBB3—Eribulin—breast cancer	0.00596	0.0321	CbGbCtD
Cabazitaxel—TUBB8—Ixabepilone—breast cancer	0.00571	0.0308	CbGbCtD
Cabazitaxel—TUBB2B—Ixabepilone—breast cancer	0.00571	0.0308	CbGbCtD
Cabazitaxel—TUBB4A—Ixabepilone—breast cancer	0.00571	0.0308	CbGbCtD
Cabazitaxel—TUBB3—Ixabepilone—breast cancer	0.00571	0.0308	CbGbCtD
Cabazitaxel—TUBB2A—Ixabepilone—breast cancer	0.00571	0.0308	CbGbCtD
Cabazitaxel—TUBB6—Ixabepilone—breast cancer	0.00571	0.0308	CbGbCtD
Cabazitaxel—ABCB1—breast cancer	0.00552	0.0558	CbGaD
Cabazitaxel—TUBB4B—Eribulin—breast cancer	0.00499	0.0269	CbGbCtD
Cabazitaxel—TUBB—Eribulin—breast cancer	0.00499	0.0269	CbGbCtD
Cabazitaxel—TUBB1—Eribulin—breast cancer	0.00499	0.0269	CbGbCtD
Cabazitaxel—TUBB—Ixabepilone—breast cancer	0.00478	0.0257	CbGbCtD
Cabazitaxel—TUBB1—Ixabepilone—breast cancer	0.00478	0.0257	CbGbCtD
Cabazitaxel—TUBB4B—Ixabepilone—breast cancer	0.00478	0.0257	CbGbCtD
Cabazitaxel—TUBB3—Vinorelbine—breast cancer	0.00305	0.0164	CbGbCtD
Cabazitaxel—TUBB2B—Vinorelbine—breast cancer	0.00305	0.0164	CbGbCtD
Cabazitaxel—TUBB8—Vinorelbine—breast cancer	0.00305	0.0164	CbGbCtD
Cabazitaxel—TUBB2A—Vinorelbine—breast cancer	0.00305	0.0164	CbGbCtD
Cabazitaxel—TUBB6—Vinorelbine—breast cancer	0.00305	0.0164	CbGbCtD
Cabazitaxel—TUBB4A—Vinorelbine—breast cancer	0.00305	0.0164	CbGbCtD
Cabazitaxel—TUBB4B—Vinorelbine—breast cancer	0.00255	0.0137	CbGbCtD
Cabazitaxel—TUBB1—Vinorelbine—breast cancer	0.00255	0.0137	CbGbCtD
Cabazitaxel—TUBB—Vinorelbine—breast cancer	0.00255	0.0137	CbGbCtD
Cabazitaxel—TUBB6—Paclitaxel—breast cancer	0.00214	0.0115	CbGbCtD
Cabazitaxel—TUBB8—Paclitaxel—breast cancer	0.00214	0.0115	CbGbCtD
Cabazitaxel—TUBB2B—Paclitaxel—breast cancer	0.00214	0.0115	CbGbCtD
Cabazitaxel—TUBB2A—Paclitaxel—breast cancer	0.00214	0.0115	CbGbCtD
Cabazitaxel—TUBB4A—Paclitaxel—breast cancer	0.00214	0.0115	CbGbCtD
Cabazitaxel—TUBB3—Paclitaxel—breast cancer	0.00214	0.0115	CbGbCtD
Cabazitaxel—TUBB4A—Vinblastine—breast cancer	0.00188	0.0101	CbGbCtD
Cabazitaxel—TUBB2B—Vinblastine—breast cancer	0.00188	0.0101	CbGbCtD
Cabazitaxel—TUBB3—Vinblastine—breast cancer	0.00188	0.0101	CbGbCtD
Cabazitaxel—TUBB2A—Vinblastine—breast cancer	0.00188	0.0101	CbGbCtD
Cabazitaxel—TUBB6—Vinblastine—breast cancer	0.00188	0.0101	CbGbCtD
Cabazitaxel—TUBB8—Vinblastine—breast cancer	0.00188	0.0101	CbGbCtD
Cabazitaxel—TUBB—Paclitaxel—breast cancer	0.00179	0.00966	CbGbCtD
Cabazitaxel—TUBB4B—Paclitaxel—breast cancer	0.00179	0.00966	CbGbCtD
Cabazitaxel—TUBB1—Paclitaxel—breast cancer	0.00179	0.00966	CbGbCtD
Cabazitaxel—TUBB—Vinblastine—breast cancer	0.00157	0.00847	CbGbCtD
Cabazitaxel—TUBB4B—Vinblastine—breast cancer	0.00157	0.00847	CbGbCtD
Cabazitaxel—TUBB1—Vinblastine—breast cancer	0.00157	0.00847	CbGbCtD
Cabazitaxel—TUBB3—Docetaxel—breast cancer	0.00155	0.00835	CbGbCtD
Cabazitaxel—TUBB2B—Docetaxel—breast cancer	0.00155	0.00835	CbGbCtD
Cabazitaxel—TUBB4A—Docetaxel—breast cancer	0.00155	0.00835	CbGbCtD
Cabazitaxel—TUBB8—Docetaxel—breast cancer	0.00155	0.00835	CbGbCtD
Cabazitaxel—TUBB2A—Docetaxel—breast cancer	0.00155	0.00835	CbGbCtD
Cabazitaxel—TUBB6—Docetaxel—breast cancer	0.00155	0.00835	CbGbCtD
Cabazitaxel—TUBB4B—Docetaxel—breast cancer	0.0013	0.00698	CbGbCtD
Cabazitaxel—TUBB1—Docetaxel—breast cancer	0.0013	0.00698	CbGbCtD
Cabazitaxel—TUBB—Docetaxel—breast cancer	0.0013	0.00698	CbGbCtD
Cabazitaxel—SLCO1B3—Paclitaxel—breast cancer	0.000765	0.00412	CbGbCtD
Cabazitaxel—SLCO1B3—Docetaxel—breast cancer	0.000553	0.00298	CbGbCtD
Cabazitaxel—CYP3A5—Lapatinib—breast cancer	0.000503	0.00271	CbGbCtD
Cabazitaxel—CYP2C8—Lapatinib—breast cancer	0.000484	0.00261	CbGbCtD
Cabazitaxel—ABCG2—Tamoxifen—breast cancer	0.000455	0.00245	CbGbCtD
Cabazitaxel—ABCB1—Toremifene—breast cancer	0.000449	0.00242	CbGbCtD
Cabazitaxel—ABCG2—Mitoxantrone—breast cancer	0.000444	0.00239	CbGbCtD
Cabazitaxel—SLCO1B1—Irinotecan—breast cancer	0.00044	0.00237	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—breast cancer	0.000399	0.00215	CbGbCtD
Cabazitaxel—CYP3A4—Exemestane—breast cancer	0.000388	0.00209	CbGbCtD
Cabazitaxel—CYP2C8—Raloxifene—breast cancer	0.000367	0.00197	CbGbCtD
Cabazitaxel—TUBA4A—Gefitinib—Lapatinib—breast cancer	0.000354	0.634	CbGdCrCtD
Cabazitaxel—ABCG2—Paclitaxel—breast cancer	0.000354	0.00191	CbGbCtD
Cabazitaxel—ABCG2—Irinotecan—breast cancer	0.000349	0.00188	CbGbCtD
Cabazitaxel—ABCG2—Fluorouracil—breast cancer	0.000335	0.00181	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—breast cancer	0.000333	0.00179	CbGbCtD
Cabazitaxel—CYP3A4—Letrozole—breast cancer	0.00033	0.00178	CbGbCtD
Cabazitaxel—ABCB1—Lapatinib—breast cancer	0.000327	0.00176	CbGbCtD
Cabazitaxel—CYP3A4—Anastrozole—breast cancer	0.000294	0.00158	CbGbCtD
Cabazitaxel—TUBA4A—mammary gland—breast cancer	0.000293	0.0276	CbGeAlD
Cabazitaxel—CYP3A4—Toremifene—breast cancer	0.000269	0.00145	CbGbCtD
Cabazitaxel—ABCG2—Docetaxel—breast cancer	0.000256	0.00138	CbGbCtD
Cabazitaxel—CYP3A5—Tamoxifen—breast cancer	0.000252	0.00136	CbGbCtD
Cabazitaxel—CYP3A4—Fulvestrant—breast cancer	0.00025	0.00135	CbGbCtD
Cabazitaxel—TUBA4A—nipple—breast cancer	0.000243	0.0229	CbGeAlD
Cabazitaxel—CYP2C8—Tamoxifen—breast cancer	0.000242	0.0013	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—breast cancer	0.000233	0.00125	CbGbCtD
Cabazitaxel—CYP3A4—Thiotepa—breast cancer	0.000223	0.0012	CbGbCtD
Cabazitaxel—TUBB6—mammary gland—breast cancer	0.000211	0.0199	CbGeAlD
Cabazitaxel—CYP3A4—Ixabepilone—breast cancer	0.000204	0.0011	CbGbCtD
Cabazitaxel—CYP3A4—Lapatinib—breast cancer	0.000196	0.00106	CbGbCtD
Cabazitaxel—CYP3A5—Paclitaxel—breast cancer	0.000196	0.00106	CbGbCtD
Cabazitaxel—SLCO1B1—mammary gland—breast cancer	0.000196	0.0184	CbGeAlD
Cabazitaxel—CYP3A5—Irinotecan—breast cancer	0.000193	0.00104	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—breast cancer	0.000191	0.00103	CbGbCtD
Cabazitaxel—CYP2C8—Paclitaxel—breast cancer	0.000189	0.00102	CbGbCtD
Cabazitaxel—TUBB2B—nipple—breast cancer	0.000188	0.0177	CbGeAlD
Cabazitaxel—ABCG2—Methotrexate—breast cancer	0.000185	0.000995	CbGbCtD
Cabazitaxel—TUBB4B—mammary gland—breast cancer	0.000183	0.0173	CbGeAlD
Cabazitaxel—ABCB1—Vinorelbine—breast cancer	0.000182	0.000978	CbGbCtD
Cabazitaxel—CYP2C8—Fluorouracil—breast cancer	0.000179	0.000962	CbGbCtD
Cabazitaxel—TUBB—nipple—breast cancer	0.000178	0.0168	CbGeAlD
Cabazitaxel—TUBB2A—nipple—breast cancer	0.000177	0.0167	CbGeAlD
Cabazitaxel—TUBB6—nipple—breast cancer	0.000175	0.0164	CbGeAlD
Cabazitaxel—TUBB1—adipose tissue—breast cancer	0.00017	0.016	CbGeAlD
Cabazitaxel—ABCB1—Tamoxifen—breast cancer	0.000164	0.000883	CbGbCtD
Cabazitaxel—TUBA4A—epithelium—breast cancer	0.000163	0.0154	CbGeAlD
Cabazitaxel—TUBB4A—embryo—breast cancer	0.000161	0.0151	CbGeAlD
Cabazitaxel—ABCB1—Mitoxantrone—breast cancer	0.00016	0.000861	CbGbCtD
Cabazitaxel—TUBA4A—skin of body—breast cancer	0.000155	0.0146	CbGeAlD
Cabazitaxel—SLCO1B3—pituitary gland—breast cancer	0.000153	0.0144	CbGeAlD
Cabazitaxel—TUBB4B—nipple—breast cancer	0.000152	0.0143	CbGeAlD
Cabazitaxel—CYP3A4—Raloxifene—breast cancer	0.000149	0.000801	CbGbCtD
Cabazitaxel—TUBB1—bone marrow—breast cancer	0.000148	0.0139	CbGeAlD
Cabazitaxel—TUBA4A—endometrium—breast cancer	0.000147	0.0138	CbGeAlD
Cabazitaxel—Paclitaxel—TUBB3—breast cancer	0.000143	0.137	CrCbGaD
Cabazitaxel—Docetaxel—TUBB3—breast cancer	0.000143	0.137	CrCbGaD
Cabazitaxel—CYP3A5—Docetaxel—breast cancer	0.000142	0.000764	CbGbCtD
Cabazitaxel—ABCB1—Gemcitabine—breast cancer	0.000141	0.000761	CbGbCtD
Cabazitaxel—TUBA4A—uterus—breast cancer	0.000135	0.0127	CbGeAlD
Cabazitaxel—TUBA4A—pituitary gland—breast cancer	0.000133	0.0125	CbGeAlD
Cabazitaxel—TUBA4A—adipose tissue—breast cancer	0.000132	0.0124	CbGeAlD
Cabazitaxel—ABCB1—Paclitaxel—breast cancer	0.000128	0.000687	CbGbCtD
Cabazitaxel—ABCB1—Irinotecan—breast cancer	0.000126	0.000678	CbGbCtD
Cabazitaxel—TUBB4B—embryo—breast cancer	0.000125	0.0118	CbGeAlD
Cabazitaxel—TUBB4A—skin of body—breast cancer	0.000125	0.0117	CbGeAlD
Cabazitaxel—TUBA4A—female reproductive system—breast cancer	0.000121	0.0114	CbGeAlD
Cabazitaxel—TUBA4A—adrenal gland—breast cancer	0.000118	0.0112	CbGeAlD
Cabazitaxel—SLCO1B3—endocrine gland—breast cancer	0.000118	0.0112	CbGeAlD
Cabazitaxel—TUBB6—epithelium—breast cancer	0.000118	0.0111	CbGeAlD
Cabazitaxel—TUBA4A—bone marrow—breast cancer	0.000115	0.0108	CbGeAlD
Cabazitaxel—TUBB2B—endometrium—breast cancer	0.000114	0.0107	CbGeAlD
Cabazitaxel—TUBB2A—skin of body—breast cancer	0.000113	0.0107	CbGeAlD
Cabazitaxel—ABCB1—Vinblastine—breast cancer	0.000112	0.000603	CbGbCtD
Cabazitaxel—TUBB6—skin of body—breast cancer	0.000112	0.0105	CbGeAlD
Cabazitaxel—CYP2C8—mammary gland—breast cancer	0.000111	0.0105	CbGeAlD
Cabazitaxel—TUBA4A—female gonad—breast cancer	0.00011	0.0104	CbGeAlD
Cabazitaxel—CYP3A4—Vinorelbine—breast cancer	0.000109	0.000586	CbGbCtD
Cabazitaxel—TUBB4A—uterus—breast cancer	0.000108	0.0102	CbGeAlD
Cabazitaxel—TUBB—endometrium—breast cancer	0.000107	0.0101	CbGeAlD
Cabazitaxel—TUBB2A—endometrium—breast cancer	0.000107	0.0101	CbGeAlD
Cabazitaxel—TUBB6—endometrium—breast cancer	0.000105	0.00993	CbGeAlD
Cabazitaxel—TUBA4A—endocrine gland—breast cancer	0.000103	0.00968	CbGeAlD
Cabazitaxel—TUBB2B—pituitary gland—breast cancer	0.000103	0.00968	CbGeAlD
Cabazitaxel—TUBB2B—adipose tissue—breast cancer	0.000102	0.00964	CbGeAlD
Cabazitaxel—TUBB—uterus—breast cancer	9.9e-05	0.00933	CbGeAlD
Cabazitaxel—TUBB2A—uterus—breast cancer	9.85e-05	0.00928	CbGeAlD
Cabazitaxel—CYP3A4—Tamoxifen—breast cancer	9.82e-05	0.000529	CbGbCtD
Cabazitaxel—TUBB4A—female reproductive system—breast cancer	9.73e-05	0.00917	CbGeAlD
Cabazitaxel—TUBB—pituitary gland—breast cancer	9.72e-05	0.00916	CbGeAlD
Cabazitaxel—TUBB4B—skin of body—breast cancer	9.72e-05	0.00915	CbGeAlD
Cabazitaxel—TUBB6—uterus—breast cancer	9.71e-05	0.00915	CbGeAlD
Cabazitaxel—TUBB—adipose tissue—breast cancer	9.68e-05	0.00912	CbGeAlD
Cabazitaxel—TUBB2A—pituitary gland—breast cancer	9.67e-05	0.00911	CbGeAlD
Cabazitaxel—TUBB2A—adipose tissue—breast cancer	9.63e-05	0.00907	CbGeAlD
Cabazitaxel—CYP3A4—Mitoxantrone—breast cancer	9.58e-05	0.000516	CbGbCtD
Cabazitaxel—TUBB6—pituitary gland—breast cancer	9.54e-05	0.00898	CbGeAlD
Cabazitaxel—TUBB6—adipose tissue—breast cancer	9.5e-05	0.00895	CbGeAlD
Cabazitaxel—TUBB4A—adrenal gland—breast cancer	9.5e-05	0.00894	CbGeAlD
Cabazitaxel—TUBB2B—female reproductive system—breast cancer	9.41e-05	0.00886	CbGeAlD
Cabazitaxel—Docetaxel—BCL2—breast cancer	9.24e-05	0.0885	CrCbGaD
Cabazitaxel—Paclitaxel—BCL2—breast cancer	9.24e-05	0.0885	CrCbGaD
Cabazitaxel—ABCB1—Docetaxel—breast cancer	9.23e-05	0.000497	CbGbCtD
Cabazitaxel—TUBB2B—adrenal gland—breast cancer	9.18e-05	0.00865	CbGeAlD
Cabazitaxel—TUBB4B—endometrium—breast cancer	9.16e-05	0.00863	CbGeAlD
Cabazitaxel—TUBB4A—female gonad—breast cancer	8.85e-05	0.00834	CbGeAlD
Cabazitaxel—TUBB2A—female reproductive system—breast cancer	8.85e-05	0.00834	CbGeAlD
Cabazitaxel—TUBB6—female reproductive system—breast cancer	8.73e-05	0.00822	CbGeAlD
Cabazitaxel—TUBB—adrenal gland—breast cancer	8.69e-05	0.00818	CbGeAlD
Cabazitaxel—TUBB2A—adrenal gland—breast cancer	8.64e-05	0.00814	CbGeAlD
Cabazitaxel—TUBB2B—female gonad—breast cancer	8.56e-05	0.00806	CbGeAlD
Cabazitaxel—TUBB6—adrenal gland—breast cancer	8.52e-05	0.00803	CbGeAlD
Cabazitaxel—TUBB4B—uterus—breast cancer	8.44e-05	0.00795	CbGeAlD
Cabazitaxel—TUBB—bone marrow—breast cancer	8.4e-05	0.00791	CbGeAlD
Cabazitaxel—Docetaxel—ABCC1—breast cancer	8.38e-05	0.0803	CrCbGaD
Cabazitaxel—Paclitaxel—ABCC1—breast cancer	8.38e-05	0.0803	CrCbGaD
Cabazitaxel—TUBB2A—bone marrow—breast cancer	8.36e-05	0.00787	CbGeAlD
Cabazitaxel—TUBB4B—pituitary gland—breast cancer	8.29e-05	0.00781	CbGeAlD
Cabazitaxel—TUBB4B—adipose tissue—breast cancer	8.26e-05	0.00778	CbGeAlD
Cabazitaxel—TUBB6—bone marrow—breast cancer	8.24e-05	0.00776	CbGeAlD
Cabazitaxel—TUBB4A—endocrine gland—breast cancer	8.23e-05	0.00776	CbGeAlD
Cabazitaxel—TUBB—female gonad—breast cancer	8.1e-05	0.00763	CbGeAlD
Cabazitaxel—SLCO1B1—female reproductive system—breast cancer	8.1e-05	0.00763	CbGeAlD
Cabazitaxel—TUBB2A—female gonad—breast cancer	8.06e-05	0.00759	CbGeAlD
Cabazitaxel—TUBB2B—endocrine gland—breast cancer	7.96e-05	0.0075	CbGeAlD
Cabazitaxel—TUBB6—female gonad—breast cancer	7.95e-05	0.00748	CbGeAlD
Cabazitaxel—CYP3A4—Paclitaxel—breast cancer	7.65e-05	0.000412	CbGbCtD
Cabazitaxel—TUBB4B—female reproductive system—breast cancer	7.59e-05	0.00715	CbGeAlD
Cabazitaxel—CYP3A4—Irinotecan—breast cancer	7.54e-05	0.000406	CbGbCtD
Cabazitaxel—TUBB2A—endocrine gland—breast cancer	7.49e-05	0.00706	CbGeAlD
Cabazitaxel—TUBB4B—adrenal gland—breast cancer	7.41e-05	0.00698	CbGeAlD
Cabazitaxel—TUBB6—endocrine gland—breast cancer	7.39e-05	0.00696	CbGeAlD
Cabazitaxel—TUBB4B—bone marrow—breast cancer	7.17e-05	0.00675	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—breast cancer	7.1e-05	0.00669	CbGeAlD
Cabazitaxel—TUBB4B—female gonad—breast cancer	6.91e-05	0.00651	CbGeAlD
Cabazitaxel—ABCB1—Doxorubicin—breast cancer	6.88e-05	0.000371	CbGbCtD
Cabazitaxel—SLCO1B1—endocrine gland—breast cancer	6.85e-05	0.00645	CbGeAlD
Cabazitaxel—CYP3A4—Vinblastine—breast cancer	6.71e-05	0.000361	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—breast cancer	6.66e-05	0.000359	CbGbCtD
Cabazitaxel—TUBB4B—endocrine gland—breast cancer	6.42e-05	0.00605	CbGeAlD
Cabazitaxel—Paclitaxel—CYP1B1—breast cancer	6.41e-05	0.0614	CrCbGaD
Cabazitaxel—Docetaxel—CYP1B1—breast cancer	6.41e-05	0.0614	CrCbGaD
Cabazitaxel—TUBB6—Zalcitabine—Gemcitabine—breast cancer	6.1e-05	0.109	CbGdCrCtD
Cabazitaxel—Docetaxel—EGFR—breast cancer	6.05e-05	0.0579	CrCbGaD
Cabazitaxel—TUBB4A—lymph node—breast cancer	5.69e-05	0.00536	CbGeAlD
Cabazitaxel—CYP2C8—endometrium—breast cancer	5.56e-05	0.00523	CbGeAlD
Cabazitaxel—CYP3A4—Docetaxel—breast cancer	5.53e-05	0.000298	CbGbCtD
Cabazitaxel—TUBB2B—lymph node—breast cancer	5.5e-05	0.00518	CbGeAlD
Cabazitaxel—ABCG2—endometrium—breast cancer	5.4e-05	0.00509	CbGeAlD
Cabazitaxel—TUBB—lymph node—breast cancer	5.21e-05	0.0049	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—breast cancer	5.18e-05	0.00488	CbGeAlD
Cabazitaxel—TUBB6—lymph node—breast cancer	5.11e-05	0.00481	CbGeAlD
Cabazitaxel—CYP2C8—pituitary gland—breast cancer	5.03e-05	0.00474	CbGeAlD
Cabazitaxel—ABCG2—uterus—breast cancer	4.98e-05	0.00469	CbGeAlD
Cabazitaxel—ABCG2—pituitary gland—breast cancer	4.89e-05	0.00461	CbGeAlD
Cabazitaxel—ABCG2—adipose tissue—breast cancer	4.87e-05	0.00459	CbGeAlD
Cabazitaxel—Paclitaxel—CYP19A1—breast cancer	4.7e-05	0.045	CrCbGaD
Cabazitaxel—CYP2C8—female reproductive system—breast cancer	4.6e-05	0.00434	CbGeAlD
Cabazitaxel—CYP3A5—adipose tissue—breast cancer	4.52e-05	0.00426	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—breast cancer	4.44e-05	0.00418	CbGeAlD
Cabazitaxel—Docetaxel—ABCG2—breast cancer	4.42e-05	0.0423	CrCbGaD
Cabazitaxel—Paclitaxel—ABCG2—breast cancer	4.42e-05	0.0423	CrCbGaD
Cabazitaxel—ABCG2—adrenal gland—breast cancer	4.37e-05	0.00411	CbGeAlD
Cabazitaxel—ABCG2—bone marrow—breast cancer	4.23e-05	0.00398	CbGeAlD
Cabazitaxel—CYP3A4—Doxorubicin—breast cancer	4.12e-05	0.000222	CbGbCtD
Cabazitaxel—ABCG2—female gonad—breast cancer	4.07e-05	0.00384	CbGeAlD
Cabazitaxel—CYP2C8—endocrine gland—breast cancer	3.9e-05	0.00367	CbGeAlD
Cabazitaxel—CYP3A5—female gonad—breast cancer	3.78e-05	0.00356	CbGeAlD
Cabazitaxel—ABCB1—embryo—breast cancer	3.64e-05	0.00343	CbGeAlD
Cabazitaxel—CYP3A5—endocrine gland—breast cancer	3.52e-05	0.00331	CbGeAlD
Cabazitaxel—TUBB6—Clomifene—Toremifene—breast cancer	3.46e-05	0.0619	CbGdCrCtD
Cabazitaxel—CYP3A4—female reproductive system—breast cancer	3.12e-05	0.00294	CbGeAlD
Cabazitaxel—TUBB—Azacitidine—Gemcitabine—breast cancer	3.1e-05	0.0555	CbGdCrCtD
Cabazitaxel—ABCB1—epithelium—breast cancer	2.97e-05	0.0028	CbGeAlD
Cabazitaxel—ABCB1—endometrium—breast cancer	2.66e-05	0.00251	CbGeAlD
Cabazitaxel—CYP3A4—endocrine gland—breast cancer	2.64e-05	0.00249	CbGeAlD
Cabazitaxel—ABCG2—lymph node—breast cancer	2.62e-05	0.00247	CbGeAlD
Cabazitaxel—ABCB1—uterus—breast cancer	2.46e-05	0.00231	CbGeAlD
Cabazitaxel—ABCB1—pituitary gland—breast cancer	2.41e-05	0.00227	CbGeAlD
Cabazitaxel—ABCB1—adipose tissue—breast cancer	2.4e-05	0.00226	CbGeAlD
Cabazitaxel—TUBB6—Tamoxifen—Toremifene—breast cancer	2.22e-05	0.0397	CbGdCrCtD
Cabazitaxel—Paclitaxel—CYP3A4—breast cancer	2.21e-05	0.0212	CrCbGaD
Cabazitaxel—Docetaxel—CYP3A4—breast cancer	2.21e-05	0.0212	CrCbGaD
Cabazitaxel—ABCB1—female reproductive system—breast cancer	2.21e-05	0.00208	CbGeAlD
Cabazitaxel—TUBB6—Clomifene—Tamoxifen—breast cancer	2.17e-05	0.0389	CbGdCrCtD
Cabazitaxel—ABCB1—adrenal gland—breast cancer	2.15e-05	0.00203	CbGeAlD
Cabazitaxel—TUBB6—Toremifene—Tamoxifen—breast cancer	2.12e-05	0.038	CbGdCrCtD
Cabazitaxel—ABCB1—bone marrow—breast cancer	2.08e-05	0.00196	CbGeAlD
Cabazitaxel—ABCB1—female gonad—breast cancer	2.01e-05	0.00189	CbGeAlD
Cabazitaxel—ABCB1—endocrine gland—breast cancer	1.87e-05	0.00176	CbGeAlD
Cabazitaxel—Docetaxel—ABCB1—breast cancer	1.84e-05	0.0176	CrCbGaD
Cabazitaxel—Paclitaxel—ABCB1—breast cancer	1.84e-05	0.0176	CrCbGaD
Cabazitaxel—ABCB1—lymph node—breast cancer	1.29e-05	0.00122	CbGeAlD
Cabazitaxel—TUBB6—Azacitidine—Gemcitabine—breast cancer	1.28e-05	0.0229	CbGdCrCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—breast cancer	6.2e-06	0.000173	CcSEcCtD
Cabazitaxel—Nervous system disorder—Capecitabine—breast cancer	6.19e-06	0.000172	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—breast cancer	6.18e-06	0.000172	CcSEcCtD
Cabazitaxel—Diarrhoea—Fluorouracil—breast cancer	6.18e-06	0.000172	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Capecitabine—breast cancer	6.18e-06	0.000172	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—breast cancer	6.17e-06	0.000172	CcSEcCtD
Cabazitaxel—Tachycardia—Capecitabine—breast cancer	6.16e-06	0.000172	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—breast cancer	6.16e-06	0.000171	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—breast cancer	6.14e-06	0.000171	CcSEcCtD
Cabazitaxel—Skin disorder—Capecitabine—breast cancer	6.13e-06	0.000171	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—breast cancer	6.12e-06	0.00017	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—breast cancer	6.1e-06	0.00017	CcSEcCtD
Cabazitaxel—Hypotension—Docetaxel—breast cancer	6.1e-06	0.00017	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—breast cancer	6.09e-06	0.000169	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—breast cancer	6.09e-06	0.000169	CcSEcCtD
Cabazitaxel—Abdominal pain—Paclitaxel—breast cancer	6.08e-06	0.000169	CcSEcCtD
Cabazitaxel—Body temperature increased—Paclitaxel—breast cancer	6.08e-06	0.000169	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—breast cancer	6.07e-06	0.000169	CcSEcCtD
Cabazitaxel—Anorexia—Capecitabine—breast cancer	6.02e-06	0.000168	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—breast cancer	6e-06	0.000167	CcSEcCtD
Cabazitaxel—Vomiting—Irinotecan—breast cancer	6e-06	0.000167	CcSEcCtD
Cabazitaxel—Vomiting—Mitoxantrone—breast cancer	6e-06	0.000167	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—breast cancer	5.98e-06	0.000166	CcSEcCtD
Cabazitaxel—Dizziness—Fluorouracil—breast cancer	5.98e-06	0.000166	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—breast cancer	5.96e-06	0.000166	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Docetaxel—breast cancer	5.94e-06	0.000165	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—breast cancer	5.94e-06	0.000165	CcSEcCtD
Cabazitaxel—Headache—Mitoxantrone—breast cancer	5.91e-06	0.000164	CcSEcCtD
Cabazitaxel—Headache—Irinotecan—breast cancer	5.91e-06	0.000164	CcSEcCtD
Cabazitaxel—Hypotension—Capecitabine—breast cancer	5.9e-06	0.000164	CcSEcCtD
Cabazitaxel—Paraesthesia—Docetaxel—breast cancer	5.86e-06	0.000163	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—breast cancer	5.85e-06	0.000163	CcSEcCtD
Cabazitaxel—Vomiting—Gemcitabine—breast cancer	5.84e-06	0.000163	CcSEcCtD
Cabazitaxel—Dyspnoea—Docetaxel—breast cancer	5.82e-06	0.000162	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—breast cancer	5.8e-06	0.000161	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—breast cancer	5.79e-06	0.000161	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—breast cancer	5.77e-06	0.000161	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—breast cancer	5.76e-06	0.00016	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—breast cancer	5.76e-06	0.00016	CcSEcCtD
Cabazitaxel—Headache—Gemcitabine—breast cancer	5.76e-06	0.00016	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Capecitabine—breast cancer	5.75e-06	0.00016	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—breast cancer	5.75e-06	0.00016	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—breast cancer	5.75e-06	0.00016	CcSEcCtD
Cabazitaxel—Vomiting—Fluorouracil—breast cancer	5.75e-06	0.00016	CcSEcCtD
Cabazitaxel—Dyspepsia—Docetaxel—breast cancer	5.74e-06	0.00016	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—breast cancer	5.7e-06	0.000159	CcSEcCtD
Cabazitaxel—Paraesthesia—Capecitabine—breast cancer	5.67e-06	0.000158	CcSEcCtD
Cabazitaxel—Decreased appetite—Docetaxel—breast cancer	5.67e-06	0.000158	CcSEcCtD
Cabazitaxel—Hypersensitivity—Paclitaxel—breast cancer	5.67e-06	0.000158	CcSEcCtD
Cabazitaxel—Headache—Fluorouracil—breast cancer	5.66e-06	0.000158	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—breast cancer	5.66e-06	0.000157	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—breast cancer	5.64e-06	0.000157	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—breast cancer	5.64e-06	0.000157	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Docetaxel—breast cancer	5.63e-06	0.000157	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—breast cancer	5.63e-06	0.000157	CcSEcCtD
Cabazitaxel—Dyspnoea—Capecitabine—breast cancer	5.63e-06	0.000157	CcSEcCtD
Cabazitaxel—Fatigue—Docetaxel—breast cancer	5.62e-06	0.000156	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—breast cancer	5.62e-06	0.000156	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—breast cancer	5.62e-06	0.000156	CcSEcCtD
Cabazitaxel—Nausea—Irinotecan—breast cancer	5.61e-06	0.000156	CcSEcCtD
Cabazitaxel—Nausea—Mitoxantrone—breast cancer	5.61e-06	0.000156	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—breast cancer	5.59e-06	0.000156	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—breast cancer	5.58e-06	0.000155	CcSEcCtD
Cabazitaxel—Pain—Docetaxel—breast cancer	5.58e-06	0.000155	CcSEcCtD
Cabazitaxel—Constipation—Docetaxel—breast cancer	5.58e-06	0.000155	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—breast cancer	5.57e-06	0.000155	CcSEcCtD
Cabazitaxel—Dyspepsia—Capecitabine—breast cancer	5.56e-06	0.000155	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—breast cancer	5.56e-06	0.000155	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—breast cancer	5.53e-06	0.000154	CcSEcCtD
Cabazitaxel—Asthenia—Paclitaxel—breast cancer	5.52e-06	0.000154	CcSEcCtD
Cabazitaxel—Decreased appetite—Capecitabine—breast cancer	5.49e-06	0.000153	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—breast cancer	5.47e-06	0.000152	CcSEcCtD
Cabazitaxel—Nausea—Gemcitabine—breast cancer	5.46e-06	0.000152	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Capecitabine—breast cancer	5.45e-06	0.000152	CcSEcCtD
Cabazitaxel—Fatigue—Capecitabine—breast cancer	5.45e-06	0.000152	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—breast cancer	5.43e-06	0.000151	CcSEcCtD
Cabazitaxel—Pain—Capecitabine—breast cancer	5.4e-06	0.00015	CcSEcCtD
Cabazitaxel—Constipation—Capecitabine—breast cancer	5.4e-06	0.00015	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—breast cancer	5.39e-06	0.00015	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—breast cancer	5.39e-06	0.00015	CcSEcCtD
Cabazitaxel—Feeling abnormal—Docetaxel—breast cancer	5.38e-06	0.00015	CcSEcCtD
Cabazitaxel—Nausea—Fluorouracil—breast cancer	5.37e-06	0.000149	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—breast cancer	5.36e-06	0.000149	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—breast cancer	5.35e-06	0.000149	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—breast cancer	5.34e-06	0.000149	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Docetaxel—breast cancer	5.33e-06	0.000148	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—breast cancer	5.32e-06	0.000148	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—breast cancer	5.32e-06	0.000148	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—breast cancer	5.32e-06	0.000148	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—breast cancer	5.28e-06	0.000147	CcSEcCtD
Cabazitaxel—Diarrhoea—Paclitaxel—breast cancer	5.27e-06	0.000147	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—breast cancer	5.21e-06	0.000145	CcSEcCtD
Cabazitaxel—Feeling abnormal—Capecitabine—breast cancer	5.2e-06	0.000145	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—breast cancer	5.2e-06	0.000145	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—breast cancer	5.19e-06	0.000145	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—breast cancer	5.18e-06	0.000144	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—breast cancer	5.18e-06	0.000144	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—breast cancer	5.18e-06	0.000144	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Capecitabine—breast cancer	5.16e-06	0.000144	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—breast cancer	5.16e-06	0.000144	CcSEcCtD
Cabazitaxel—Body temperature increased—Docetaxel—breast cancer	5.16e-06	0.000143	CcSEcCtD
Cabazitaxel—Abdominal pain—Docetaxel—breast cancer	5.16e-06	0.000143	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—breast cancer	5.16e-06	0.000143	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—breast cancer	5.14e-06	0.000143	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—breast cancer	5.12e-06	0.000142	CcSEcCtD
Cabazitaxel—Dizziness—Paclitaxel—breast cancer	5.09e-06	0.000142	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—breast cancer	5.06e-06	0.000141	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—breast cancer	5.03e-06	0.00014	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—breast cancer	5.02e-06	0.00014	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—breast cancer	5e-06	0.000139	CcSEcCtD
Cabazitaxel—Body temperature increased—Capecitabine—breast cancer	4.99e-06	0.000139	CcSEcCtD
Cabazitaxel—Abdominal pain—Capecitabine—breast cancer	4.99e-06	0.000139	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—breast cancer	4.99e-06	0.000139	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—breast cancer	4.99e-06	0.000139	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—breast cancer	4.98e-06	0.000139	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—breast cancer	4.9e-06	0.000136	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—breast cancer	4.9e-06	0.000136	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—breast cancer	4.9e-06	0.000136	CcSEcCtD
Cabazitaxel—Vomiting—Paclitaxel—breast cancer	4.89e-06	0.000136	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—breast cancer	4.88e-06	0.000136	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.87e-06	0.000136	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—breast cancer	4.86e-06	0.000135	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—breast cancer	4.85e-06	0.000135	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—breast cancer	4.84e-06	0.000135	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—breast cancer	4.83e-06	0.000134	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—breast cancer	4.83e-06	0.000134	CcSEcCtD
Cabazitaxel—Headache—Paclitaxel—breast cancer	4.82e-06	0.000134	CcSEcCtD
Cabazitaxel—Hypersensitivity—Docetaxel—breast cancer	4.81e-06	0.000134	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—breast cancer	4.8e-06	0.000133	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—breast cancer	4.74e-06	0.000132	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—breast cancer	4.7e-06	0.000131	CcSEcCtD
Cabazitaxel—Asthenia—Docetaxel—breast cancer	4.68e-06	0.00013	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—breast cancer	4.67e-06	0.00013	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—breast cancer	4.65e-06	0.00013	CcSEcCtD
Cabazitaxel—Hypersensitivity—Capecitabine—breast cancer	4.65e-06	0.000129	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—breast cancer	4.63e-06	0.000129	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—breast cancer	4.61e-06	0.000128	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—breast cancer	4.61e-06	0.000128	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—breast cancer	4.6e-06	0.000128	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—breast cancer	4.59e-06	0.000128	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—breast cancer	4.59e-06	0.000128	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—breast cancer	4.59e-06	0.000128	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—breast cancer	4.57e-06	0.000127	CcSEcCtD
Cabazitaxel—Nausea—Paclitaxel—breast cancer	4.57e-06	0.000127	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—breast cancer	4.57e-06	0.000127	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.56e-06	0.000127	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—breast cancer	4.53e-06	0.000126	CcSEcCtD
Cabazitaxel—Asthenia—Capecitabine—breast cancer	4.53e-06	0.000126	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—breast cancer	4.5e-06	0.000125	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—breast cancer	4.49e-06	0.000125	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—breast cancer	4.48e-06	0.000125	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—breast cancer	4.48e-06	0.000125	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—breast cancer	4.47e-06	0.000124	CcSEcCtD
Cabazitaxel—Diarrhoea—Docetaxel—breast cancer	4.46e-06	0.000124	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—breast cancer	4.44e-06	0.000123	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—breast cancer	4.4e-06	0.000122	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—breast cancer	4.39e-06	0.000122	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—breast cancer	4.37e-06	0.000122	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—breast cancer	4.35e-06	0.000121	CcSEcCtD
Cabazitaxel—Diarrhoea—Capecitabine—breast cancer	4.32e-06	0.00012	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—breast cancer	4.31e-06	0.00012	CcSEcCtD
Cabazitaxel—Dizziness—Docetaxel—breast cancer	4.31e-06	0.00012	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—breast cancer	4.31e-06	0.00012	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—breast cancer	4.31e-06	0.00012	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—breast cancer	4.29e-06	0.000119	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—breast cancer	4.28e-06	0.000119	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—breast cancer	4.27e-06	0.000119	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—breast cancer	4.25e-06	0.000118	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—breast cancer	4.25e-06	0.000118	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—breast cancer	4.25e-06	0.000118	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—breast cancer	4.23e-06	0.000118	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—breast cancer	4.22e-06	0.000117	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.22e-06	0.000117	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—breast cancer	4.2e-06	0.000117	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—breast cancer	4.19e-06	0.000117	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—breast cancer	4.19e-06	0.000117	CcSEcCtD
Cabazitaxel—Dizziness—Capecitabine—breast cancer	4.18e-06	0.000116	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—breast cancer	4.15e-06	0.000116	CcSEcCtD
Cabazitaxel—Vomiting—Docetaxel—breast cancer	4.15e-06	0.000115	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—breast cancer	4.14e-06	0.000115	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—breast cancer	4.11e-06	0.000114	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—breast cancer	4.1e-06	0.000114	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—breast cancer	4.09e-06	0.000114	CcSEcCtD
Cabazitaxel—Headache—Docetaxel—breast cancer	4.09e-06	0.000114	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—breast cancer	4.07e-06	0.000113	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—breast cancer	4.06e-06	0.000113	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—breast cancer	4.05e-06	0.000113	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—breast cancer	4.04e-06	0.000113	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—breast cancer	4.02e-06	0.000112	CcSEcCtD
Cabazitaxel—Vomiting—Capecitabine—breast cancer	4.02e-06	0.000112	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—breast cancer	4.01e-06	0.000112	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—breast cancer	3.99e-06	0.000111	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—breast cancer	3.99e-06	0.000111	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—breast cancer	3.97e-06	0.000111	CcSEcCtD
Cabazitaxel—Headache—Capecitabine—breast cancer	3.96e-06	0.00011	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—breast cancer	3.95e-06	0.00011	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—breast cancer	3.95e-06	0.00011	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—breast cancer	3.92e-06	0.000109	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—breast cancer	3.88e-06	0.000108	CcSEcCtD
Cabazitaxel—Nausea—Docetaxel—breast cancer	3.87e-06	0.000108	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—breast cancer	3.87e-06	0.000108	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—breast cancer	3.87e-06	0.000108	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—breast cancer	3.84e-06	0.000107	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—breast cancer	3.82e-06	0.000106	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—breast cancer	3.8e-06	0.000106	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—breast cancer	3.8e-06	0.000106	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—breast cancer	3.79e-06	0.000106	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—breast cancer	3.76e-06	0.000105	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—breast cancer	3.76e-06	0.000105	CcSEcCtD
Cabazitaxel—Nausea—Capecitabine—breast cancer	3.75e-06	0.000104	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—breast cancer	3.72e-06	0.000103	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—breast cancer	3.72e-06	0.000103	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.71e-06	0.000103	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—breast cancer	3.66e-06	0.000102	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—breast cancer	3.63e-06	0.000101	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—breast cancer	3.63e-06	0.000101	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—breast cancer	3.6e-06	0.0001	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—breast cancer	3.58e-06	9.97e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—breast cancer	3.54e-06	9.85e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—breast cancer	3.51e-06	9.78e-05	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—breast cancer	3.51e-06	9.77e-05	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—breast cancer	3.48e-06	9.69e-05	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—breast cancer	3.48e-06	9.69e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—breast cancer	3.48e-06	9.68e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—breast cancer	3.48e-06	9.68e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—breast cancer	3.46e-06	9.64e-05	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—breast cancer	3.37e-06	9.39e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—breast cancer	3.35e-06	9.34e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—breast cancer	3.33e-06	9.26e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—breast cancer	3.24e-06	9.02e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—breast cancer	3.22e-06	8.96e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—breast cancer	3.22e-06	8.96e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—breast cancer	3.22e-06	8.95e-05	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—breast cancer	3.16e-06	8.78e-05	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—breast cancer	3.11e-06	8.65e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—breast cancer	3.01e-06	8.38e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—breast cancer	3e-06	8.35e-05	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—breast cancer	2.99e-06	8.32e-05	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—breast cancer	2.95e-06	8.2e-05	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—breast cancer	2.92e-06	8.13e-05	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—breast cancer	2.91e-06	8.1e-05	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—breast cancer	2.8e-06	7.78e-05	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—breast cancer	2.79e-06	7.77e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—breast cancer	2.79e-06	7.75e-05	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—breast cancer	2.76e-06	7.67e-05	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—breast cancer	2.69e-06	7.49e-05	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—breast cancer	2.61e-06	7.27e-05	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—breast cancer	2.59e-06	7.2e-05	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—breast cancer	2.55e-06	7.1e-05	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—breast cancer	2.42e-06	6.73e-05	CcSEcCtD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	5.72e-07	2.52e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HPGDS—breast cancer	5.7e-07	2.51e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NCOR1—breast cancer	5.68e-07	2.49e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PLA2G4A—breast cancer	5.68e-07	2.49e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—breast cancer	5.68e-07	2.49e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HBA1—breast cancer	5.67e-07	2.49e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NOS3—breast cancer	5.62e-07	2.47e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ESRRA—breast cancer	5.59e-07	2.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ANGPTL4—breast cancer	5.59e-07	2.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—FASN—breast cancer	5.59e-07	2.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—BCHE—breast cancer	5.56e-07	2.44e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	5.54e-07	2.43e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—breast cancer	5.53e-07	2.43e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ACHE—breast cancer	5.53e-07	2.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC5A5—breast cancer	5.49e-07	2.41e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—DPYD—breast cancer	5.45e-07	2.39e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MED12—breast cancer	5.45e-07	2.39e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GPX1—breast cancer	5.44e-07	2.39e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTHFR—breast cancer	5.42e-07	2.38e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1A1—breast cancer	5.38e-07	2.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALDOA—breast cancer	5.36e-07	2.36e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ERCC2—breast cancer	5.34e-07	2.35e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC2A1—breast cancer	5.31e-07	2.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NQO1—breast cancer	5.31e-07	2.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPI—breast cancer	5.3e-07	2.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HADHB—breast cancer	5.3e-07	2.33e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP17A1—breast cancer	5.23e-07	2.3e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA3—breast cancer	5.21e-07	2.29e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CB—breast cancer	5.19e-07	2.28e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS1—breast cancer	5.18e-07	2.28e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO1—breast cancer	5.18e-07	2.28e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP3A4—breast cancer	5.17e-07	2.27e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC2A2—breast cancer	5.17e-07	2.27e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.16e-07	2.27e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—breast cancer	5.14e-07	2.26e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.1e-07	2.24e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1B1—breast cancer	5.09e-07	2.24e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2D6—breast cancer	5.08e-07	2.23e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ABCG2—breast cancer	5.07e-07	2.23e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTR—breast cancer	5.07e-07	2.23e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CPT1A—breast cancer	5.07e-07	2.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.05e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.05e-07	2.22e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTHFR—breast cancer	5.02e-07	2.2e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CAV1—breast cancer	5e-07	2.2e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HSP90AA1—breast cancer	4.99e-07	2.19e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOA2—breast cancer	4.99e-07	2.19e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HPGDS—breast cancer	4.97e-07	2.18e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HBA1—breast cancer	4.94e-07	2.17e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOA1—breast cancer	4.85e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PHGDH—breast cancer	4.84e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UMPS—breast cancer	4.84e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ADSL—breast cancer	4.84e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NME1—breast cancer	4.84e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—FHL2—breast cancer	4.84e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—FASN—breast cancer	4.84e-07	2.13e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—breast cancer	4.82e-07	2.12e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ACHE—breast cancer	4.82e-07	2.12e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—BCHE—breast cancer	4.82e-07	2.12e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP19A1—breast cancer	4.78e-07	2.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—STK11—breast cancer	4.78e-07	2.1e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.77e-07	2.1e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC5A5—breast cancer	4.76e-07	2.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—LDHB—breast cancer	4.75e-07	2.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BRIP1—breast cancer	4.75e-07	2.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HPSE—breast cancer	4.75e-07	2.09e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.68e-07	2.05e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CAV1—breast cancer	4.63e-07	2.03e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NQO1—breast cancer	4.6e-07	2.02e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC2A1—breast cancer	4.6e-07	2.02e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP17A1—breast cancer	4.56e-07	2e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CG—breast cancer	4.55e-07	2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO1—breast cancer	4.51e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS1—breast cancer	4.51e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCC1—breast cancer	4.5e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA3—breast cancer	4.5e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HMMR—breast cancer	4.5e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.5e-07	1.98e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—breast cancer	4.49e-07	1.97e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP3A4—breast cancer	4.48e-07	1.97e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.46e-07	1.96e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—COMT—breast cancer	4.45e-07	1.95e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2D6—breast cancer	4.43e-07	1.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—breast cancer	4.43e-07	1.94e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1B1—breast cancer	4.41e-07	1.94e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HMOX1—breast cancer	4.36e-07	1.92e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.36e-07	1.92e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ITPR1—breast cancer	4.35e-07	1.91e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA2—breast cancer	4.35e-07	1.91e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HSP90AA1—breast cancer	4.32e-07	1.9e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	4.22e-07	1.86e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CG—breast cancer	4.21e-07	1.85e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—FASN—breast cancer	4.21e-07	1.85e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOA1—breast cancer	4.2e-07	1.85e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—BCHE—breast cancer	4.2e-07	1.84e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCB1—breast cancer	4.19e-07	1.84e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC5A5—breast cancer	4.15e-07	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP19A1—breast cancer	4.14e-07	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—STK11—breast cancer	4.14e-07	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA4—breast cancer	4.12e-07	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CA9—breast cancer	4.12e-07	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMS—breast cancer	4.11e-07	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—breast cancer	4.07e-07	1.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOR1—breast cancer	4.07e-07	1.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.07e-07	1.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPX2—breast cancer	4.01e-07	1.76e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA2—breast cancer	4.01e-07	1.76e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC2A1—breast cancer	4e-07	1.76e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NQO1—breast cancer	4e-07	1.76e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CD—breast cancer	4e-07	1.76e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPX4—breast cancer	3.96e-07	1.74e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SULT1A1—breast cancer	3.96e-07	1.74e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALB—breast cancer	3.95e-07	1.74e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP3A4—breast cancer	3.9e-07	1.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GPX1—breast cancer	3.89e-07	1.71e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.89e-07	1.71e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—IDH1—breast cancer	3.87e-07	1.7e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA1—breast cancer	3.87e-07	1.7e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1A1—breast cancer	3.86e-07	1.69e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—COMT—breast cancer	3.85e-07	1.69e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1B1—breast cancer	3.84e-07	1.69e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—breast cancer	3.83e-07	1.68e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NAT2—breast cancer	3.83e-07	1.68e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ERCC2—breast cancer	3.82e-07	1.68e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.82e-07	1.68e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HMOX1—breast cancer	3.78e-07	1.66e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NOS3—breast cancer	3.78e-07	1.66e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ITPR1—breast cancer	3.77e-07	1.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HSP90AA1—breast cancer	3.76e-07	1.65e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CD—breast cancer	3.71e-07	1.63e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA1—breast cancer	3.66e-07	1.61e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALB—breast cancer	3.66e-07	1.61e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCB1—breast cancer	3.63e-07	1.59e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—STK11—breast cancer	3.61e-07	1.59e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP19A1—breast cancer	3.61e-07	1.59e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTHFR—breast cancer	3.59e-07	1.58e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMS—breast cancer	3.56e-07	1.57e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOR1—breast cancer	3.52e-07	1.55e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—breast cancer	3.52e-07	1.55e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PLA2G4A—breast cancer	3.52e-07	1.55e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NOS3—breast cancer	3.5e-07	1.54e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CB—breast cancer	3.49e-07	1.53e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—breast cancer	3.46e-07	1.52e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GPX1—breast cancer	3.37e-07	1.48e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MED12—breast cancer	3.36e-07	1.48e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—DPYD—breast cancer	3.36e-07	1.48e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—COMT—breast cancer	3.36e-07	1.47e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—breast cancer	3.34e-07	1.47e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1A1—breast cancer	3.34e-07	1.47e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CAV1—breast cancer	3.32e-07	1.46e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ERCC2—breast cancer	3.31e-07	1.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDOA—breast cancer	3.3e-07	1.45e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HMOX1—breast cancer	3.29e-07	1.45e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ITPR1—breast cancer	3.29e-07	1.44e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CB—breast cancer	3.23e-07	1.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA3—breast cancer	3.21e-07	1.41e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—breast cancer	3.2e-07	1.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC2A2—breast cancer	3.19e-07	1.4e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—breast cancer	3.16e-07	1.39e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CPT1A—breast cancer	3.12e-07	1.37e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTR—breast cancer	3.12e-07	1.37e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCG2—breast cancer	3.12e-07	1.37e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTHFR—breast cancer	3.11e-07	1.37e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMS—breast cancer	3.1e-07	1.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PLA2G4A—breast cancer	3.07e-07	1.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOR1—breast cancer	3.07e-07	1.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—breast cancer	3.07e-07	1.35e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HPGDS—breast cancer	3.06e-07	1.34e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HBA1—breast cancer	3.04e-07	1.34e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CG—breast cancer	3.02e-07	1.33e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—breast cancer	3.01e-07	1.32e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—breast cancer	2.97e-07	1.3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ACHE—breast cancer	2.97e-07	1.3e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GPX1—breast cancer	2.94e-07	1.29e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1A1—breast cancer	2.91e-07	1.28e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ERCC2—breast cancer	2.89e-07	1.27e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CAV1—breast cancer	2.87e-07	1.26e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP17A1—breast cancer	2.81e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—breast cancer	2.79e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO1—breast cancer	2.78e-07	1.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS1—breast cancer	2.78e-07	1.22e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.74e-07	1.21e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2D6—breast cancer	2.73e-07	1.2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTHFR—breast cancer	2.71e-07	1.19e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA2—breast cancer	2.68e-07	1.18e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CD—breast cancer	2.65e-07	1.17e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALB—breast cancer	2.62e-07	1.15e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CG—breast cancer	2.62e-07	1.15e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—FASN—breast cancer	2.6e-07	1.14e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BCHE—breast cancer	2.59e-07	1.14e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—breast cancer	2.59e-07	1.14e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC5A5—breast cancer	2.55e-07	1.12e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NOS3—breast cancer	2.51e-07	1.1e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CAV1—breast cancer	2.5e-07	1.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NQO1—breast cancer	2.47e-07	1.08e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC2A1—breast cancer	2.47e-07	1.08e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1B1—breast cancer	2.37e-07	1.04e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.32e-07	1.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CB—breast cancer	2.31e-07	1.02e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CD—breast cancer	2.3e-07	1.01e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—breast cancer	2.29e-07	1.01e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CG—breast cancer	2.28e-07	1e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALB—breast cancer	2.27e-07	9.98e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA1—breast cancer	2.26e-07	9.92e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—STK11—breast cancer	2.22e-07	9.77e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP19A1—breast cancer	2.22e-07	9.77e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NOS3—breast cancer	2.17e-07	9.54e-06	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—breast cancer	2.13e-07	9.34e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—COMT—breast cancer	2.07e-07	9.08e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—breast cancer	2.06e-07	9.04e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HMOX1—breast cancer	2.03e-07	8.92e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ITPR1—breast cancer	2.02e-07	8.9e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CB—breast cancer	2e-07	8.81e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CD—breast cancer	2e-07	8.8e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—breast cancer	2e-07	8.79e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—breast cancer	1.99e-07	8.73e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALB—breast cancer	1.98e-07	8.69e-06	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—breast cancer	1.97e-07	8.65e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCB1—breast cancer	1.95e-07	8.56e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMS—breast cancer	1.91e-07	8.41e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NOS3—breast cancer	1.89e-07	8.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.89e-07	8.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—breast cancer	1.89e-07	8.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOR1—breast cancer	1.89e-07	8.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPX1—breast cancer	1.81e-07	7.96e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1A1—breast cancer	1.79e-07	7.88e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ERCC2—breast cancer	1.78e-07	7.81e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CB—breast cancer	1.75e-07	7.67e-06	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—breast cancer	1.74e-07	7.63e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—breast cancer	1.73e-07	7.61e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—breast cancer	1.73e-07	7.6e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTHFR—breast cancer	1.67e-07	7.34e-06	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—breast cancer	1.61e-07	7.07e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CAV1—breast cancer	1.54e-07	6.77e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—breast cancer	1.51e-07	6.63e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—breast cancer	1.41e-07	6.2e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CG—breast cancer	1.4e-07	6.17e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CD—breast cancer	1.23e-07	5.42e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—breast cancer	1.22e-07	5.37e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALB—breast cancer	1.22e-07	5.35e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NOS3—breast cancer	1.17e-07	5.12e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—breast cancer	1.15e-07	5.06e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CB—breast cancer	1.08e-07	4.73e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—breast cancer	1.07e-07	4.68e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—breast cancer	1.06e-07	4.68e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—breast cancer	9.98e-08	4.39e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—breast cancer	9.3e-08	4.09e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—breast cancer	8.7e-08	3.82e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—breast cancer	6.56e-08	2.88e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—breast cancer	5.36e-08	2.35e-06	CbGpPWpGaD
